Description:
"Chapter I of this year’s World Drug Report provides an
overview of recent trends and the drug situation in terms
of production, trafficking and consumption and the consequences of illicit drug use in terms of treatment, drugrelated diseases and drug-related deaths.
Chapter II presents a long-term perspective on the characteristics and evolution of the drug problem and the main
factors that shaped it. It starts with a discussion of the main
characteristics of the contemporary drug problem, followed
by an overview of the shifts observed over the last few
de cades, before concluding with an analysis of the driving
factors that shaped the evolution of the drug problem,
including a brief outlook for its likely future direction. CHAPTER I. RECENT STATISTICS
AND TREND ANALYSIS OF ILLICIT
DRUG MARKETS
Latest available data indicate that there has been no significant change in the global status quo regarding the use,
production and health consequences of illicit drugs, other
than the return to high levels of opium production in
Afghanistan after a disease of the opium poppy and subsequent crop failure in 2010. But while the troubled waters
of the world’s illicit drug markets may appear to be stagnant, shifts and changes in their flows and currents can be
observed below the surface. These are significant and also
worrying, not because of how they currently impact on
the data but because they are proof of the resilience and
adaptability of illicit drug suppliers and users and because
of the potential future repercussions of those shifts and
changes in the world’s major drug markets.
The global picture
The extent of global illicit drug use remained stable in the
five years up to and including 2010, at between 3.4 and
6.6 per cent of the adult population (persons aged 15-64).
However, some 10-13 per cent of drug users continue to
be problem users with drug dependence and/or drug-use
disorders, the prevalence of HIV (estimated at approximately 20 per cent), hepatitis C (46.7 per cent) and hepatitis B (14.6 per cent) among injecting drug users continues
to add to the global burden of disease, and, last but not
least, approximately 1 in every 100 deaths among adults
is attributed to illicit drug use.
Opioids continue to be the dominant drug type accounting for treatment demand in Asia and Europe and also
contribute considerably to treatment demand in Africa,
North America and Oceania. Treatment for cocaine use is
mainly associated with the Americas, while cannabis is the
main drug causing treatment demand in Africa. Demand
for treatment relating to the use of amphetamine-type
stimulants (ATS) is most common in Asia..."
Source/publisher:
UNODC (United Nations Office on Drugs and Crime)
Date of Publication:
2012-00-00
Date of entry:
2019-07-08
Grouping:
- Individual Documents
Category:
Countries:
Myanmar
Language:
English
Local URL:
Format:
pdf
Size:
12.33 MB
Resource Type:
text
Text quality:
- Good